This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Should You Buy AXT (AXTI) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AXTINo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ABCLNegative Net Change JAZZPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Applied Materials (AMAT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
AMATNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
SentinelOne (S) Moves 9.8% Higher: Will This Strength Last?
by Zacks Equity Research
SentinelOne (S) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SNegative Net Change QLYSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beyond (BYON) Moves 22.5% Higher: Will This Strength Last?
by Zacks Equity Research
Beyond (BYON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BYONNegative Net Change EBAYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CDNAPositive Net Change SNDAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Uniti (UNIT) Moves 10.2% Higher: Will This Strength Last?
by Zacks Equity Research
Uniti (UNIT) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term.
UNITPositive Net Change HSTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stem (STEM) Surges 45.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Stem (STEM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STEMPositive Net Change TBLANo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Dell Technologies (DELL) Moves 5.9% Higher: Will This Strength Last?
by Zacks Equity Research
Dell Technologies (DELL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
DELLNegative Net Change LNVGYNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RXRXNegative Net Change ANIKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Chemung Financial (CHMG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CHMGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Invesco (IVZ) Surges 15.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Invesco (IVZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
IVZPositive Net Change SAMGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Radcom (RDCM): Can Its 11.4% Jump Turn into More Strength?
by Zacks Equity Research
Radcom (RDCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RDCMPositive Net Change NTCTNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Eos Energy Enterprises (EOSE) Surges 10.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Eos Energy Enterprises (EOSE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EOSENegative Net Change LZPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Materion (MTRN): Can Its 6.3% Jump Turn into More Strength?
by Zacks Equity Research
Materion (MTRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MTRNPositive Net Change GSMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in California Resources (CRC): Can Its 6.7% Jump Turn into More Strength?
by Zacks Equity Research
California Resources (CRC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRCPositive Net Change MNRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cheniere Energy (LNG) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Cheniere Energy (LNG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LNGPositive Net Change NOGPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Zeta (ZETA) Moves 6.2% Higher: Will This Strength Last?
by Zacks Equity Research
Zeta (ZETA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZETANegative Net Change TTECPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BlackSky Technology (BKSY) Moves 8.9% Higher: Will This Strength Last?
by Zacks Equity Research
BlackSky Technology (BKSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BKSYNegative Net Change ALLTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Pagaya Technologies Ltd. (PGY) Soars 25.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Pagaya Technologies Ltd. (PGY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PGYNegative Net Change XPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in StepStone Group (STEP): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
StepStone Group (STEP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STEPNegative Net Change HLIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
BeOne Medicines Ltd. - Sponsored ADR (ONC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ONCPositive Net Change MGXPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Zymeworks (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ZYMENegative Net Change CYTKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Datadog (DDOG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DDOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Western Digital (WDC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
WDCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines